Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LDHA | P00338 | 1/20 | 0.57 |
| ▸ | SRR | Q9GZT4 | 1/20 | 0.57 |
| ▸ | OR51E2 | Q9H255 | 3/20 | 0.50 |
| ▸ | EGLN1 | Q9GZT9 | 2/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | SLC13A3 | Q8WWT9 | 1/20 | 0.50 |
| ▸ | FEN1 | P39748 | 4/20 | 0.42 |
| ▸ | ERCC5 | P28715 | 3/20 | 0.42 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 3/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | HAO1 | Q9UJM8 | 3/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.38 |
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.38 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.35 |
| ▸ | GLRA1 | P23415 | 1/20 | 0.35 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Oxaloacetate SCHEMBL4298763 | 1.00 | LDHA (0.57) | LDHASRROR51E2EGLN1MAPK1 | |
| Oxaloacetate SCHEMBL8464 | 1.00 | — | — | |
| Oxaloacetate SCHEMBL6545252 | 0.96 | LDHA (0.53) | LDHASRROR51E2EGLN1MAPK1 | |
| Oxaloacetate SCHEMBL20912993 | 0.96 | LDHA (0.53) | LDHASRROR51E2EGLN1MAPK1 | |
| Oxaloacetate SCHEMBL9994505 | 0.96 | LDHA (0.53) | LDHASRROR51E2EGLN1MAPK1 | |
| Oxaloacetate SCHEMBL25210523 | 0.96 | — | — | |
| Oxaloacetate SCHEMBL6545256 | 0.96 | LDHA (0.53) | LDHASRROR51E2EGLN1MAPK1 | |
| Oxaloacetate SCHEMBL9782818 | 0.96 | LDHA (0.53) | LDHASRROR51E2EGLN1MAPK1 | |
| Oxaloacetate SCHEMBL11328361 | 0.96 | LDHA (0.53) | LDHASRROR51E2EGLN1MAPK1 | |
| Oxaloacetate SCHEMBL8638879 | 0.96 | LDHA (0.53) | LDHASRROR51E2EGLN1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250262177-A1 | METHOD TO ALLEVIATE THE SYMPTOMS OF PMS | CASH ALAN B (US) | 2025-08-21 | — | — | US | disclosed |
| US-12324794-B2 | Method to alleviate the symptoms of PMS | CASH ALAN B (US) | 2025-06-10 | — | — | US | disclosed |
| US-20250079000-A1 | METHODS AND MARKERS FOR DIAGNOSIS OF PARKINSON'S DISEASE | BERG SURVIVOR’S TRUST | 2025-03-06 | — | — | US | disclosed |
| US-20240115529-A1 | METHOD TO ALLEVIATE THE SYMPTOMS OF PMS | CASH ALAN B (US) | 2024-04-11 | — | — | US | disclosed |
| US-11865092-B2 | Method to alleviate the symptoms of PMS | CASH, ALAN B. | 2024-01-09 | — | — | US | disclosed |
| EP-3515428-B1 | METHOD TO ALLEVIATE THE SYMPTOMS OF PMS | CASH ALAN B (US) | 2023-06-07 | — | — | EP | disclosed |
| WO-2022241292-A2 | USE OF MARKERS IN THE DIAGNOSIS AND TREATMENT OF PARKINSON'S DISEASE | BERG LLC (US) | 2022-11-17 | — | — | WO | disclosed |
| CN-110382685-A | For improving the biology and method of the expression plum surprise yeast xylose transport albumen of xylose absorption | 创新生物科学公司 | 2019-10-25 | — | — | CN | disclosed |
| CN-110325640-A | Plum surprise yeast kind for compound biosynthesis | 创新生物科学公司 | 2019-10-11 | — | — | CN | disclosed |
| CN-104718292-B | The microorganism of carbon dioxide fixation circulation is imported | 三井化学株式会社 | 2019-09-10 | — | — | CN | disclosed |
| EP-1599169-A4 | METHOD FOR INCREASING HAIR GROWTH | E L MANAGEMENT CORP (US) | 2008-01-23 | — | — | EP | disclosed |
| CN-1852986-A | Production of polyunsaturated fatty acids in oleaginous yeast | DU PONT (US) | 2006-10-25 | — | — | CN | disclosed |
| CN-1816559-A | Codon-optimized genes for the production of polyunsaturated fatty acids in oleaginous yeasts | DU PONT (US) | 2006-08-09 | — | — | CN | disclosed |
| US-20050271739-A1 | Methods and compositions for accelerating alcohol metabolism | ENZYMEDIX | 2005-12-08 | — | — | US | disclosed |
| EP-1599169-A2 | METHOD FOR INCREASING HAIR GROWTH | E-L Management Corp. (US) | 2005-11-30 | — | — | EP | disclosed |
| WO-2004078117-A2 | METHOD FOR INCREASING HAIR GROWTH | E-L MANAGEMENT CORP. (US) | 2004-09-16 | — | — | WO | disclosed |
| US-20040171693-A1 | Method for increasing hair growth | GAN DAVID C (US) | 2004-09-02 | — | — | US | disclosed |
| EP-0973938-A4 | THE USE OF NADPH AND NADH ANALOGS IN THE MEASUREMENT OF ENZYME ACTIVITIES AND METABOLITES | SPECIALTY ASSAYS INC (US) | 2000-04-26 | — | — | EP | disclosed |
| EP-0973938-A1 | THE USE OF NADPH AND NADH ANALOGS IN THE MEASUREMENT OF ENZYME ACTIVITIES AND METABOLITES | Specialty Assays, Inc. (US) | 2000-01-26 | — | — | EP | disclosed |
| WO-1998033936-A1 | THE USE OF NADPH AND NADH ANALOGS IN THE MEASUREMENT OF ENZYME ACTIVITIES AND METABOLITES | SPECIALTY ASSAYS, INC. (US) | 1998-08-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050271739-A1 | Methods and compositions for accelerating alcohol metabolism | ADH1A, ADH1C, ADH5 | LDHA 285/4885SRR 594/4885OR51E2 4615/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.